Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Free Cash Flow (2016 - 2025)

Rockwell Medical's Free Cash Flow history spans 16 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 369.15% year-over-year to $2.2 million; the TTM value through Dec 2025 reached -$1.2 million, down 137.64%, while the annual FY2025 figure was -$1.2 million, 137.64% down from the prior year.
  • Free Cash Flow reached $2.2 million in Q4 2025 per RMTI's latest filing, up from -$1.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $4.1 million in Q3 2024 to a low of -$12.5 million in Q1 2021.
  • Average Free Cash Flow over 5 years is -$2.9 million, with a median of -$2.2 million recorded in 2023.
  • Peak YoY movement for Free Cash Flow: plummeted 268.79% in 2023, then skyrocketed 646.51% in 2024.
  • A 5-year view of Free Cash Flow shows it stood at -$9.1 million in 2021, then skyrocketed by 95.7% to -$393000.0 in 2022, then soared by 78.12% to -$86000.0 in 2023, then surged by 646.51% to $470000.0 in 2024, then soared by 369.15% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Free Cash Flow are $2.2 million (Q4 2025), -$1.5 million (Q3 2025), and $1.7 million (Q2 2025).